Kendrion

Kendrion, a Netherlands-based Electromedical and Electrotherapeutic Apparatus Manufacturing company, reported global carbon emissions of approximately 71,904,000 kg CO2e in 2025. This total comprised 1,406,000 kg CO2e from Scope 1 emissions, 303,000 kg CO2e from Scope 2 market-based emissions, and 70,195,000 kg CO2e from Scope 3 emissions.

In 2024, Kendrion's total global emissions were approximately 111,823,000 kg CO2e, including 1,224,000 kg CO2e for Scope 1, 667,000 kg CO2e for Scope 2 market-based, and 109,932,000 kg CO2e for Scope 3.

Looking back to 2023, Kendrion disclosed Scope 1 emissions of 1,182,000 kg CO2e and Scope 2 market-based emissions of 1,687,000 kg CO2e. Scope 3 data was not available for 2023. In 2022, Scope 1 and 2 emissions combined totalled 5,833,000 kg CO2e. Historical data shows combined Scope 1 and 2 emissions of 6,698,000 kg CO2e in 2019, 7,322,000 kg CO2e in 2018, 7,098,000 kg CO2e in 2017, 7,187,000 kg CO2e in 2016, and 12,452,000 kg CO2e in 2015.

Kendrion has set ambitious climate commitments. The company aims for a 70% absolute reduction of energy consumption and CO2 emissions across all scopes by the end of 2028, with 2024 as the baseline. The company also previously aimed for a 15% relative reduction in Scope 1 and Scope 2 energy consumption and CO2 emissions by the end of 2023, against a 2019 baseline. Furthermore, Kendrion is working towards net-zero Scope 1 and Scope 2 emissions by 2050, primarily through transitioning its entire electricity supply to renewable energy.